BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 20, 2022
View Archived Issues
TLR2/6 agonist AXA-042 shows antitumor activity and tolerability in vivo
Read More
Plexium compound shows the promise of BRD4 degradation for prostate cancer
Read More
Guangzhou Fermion Technology patents new CDK7 inhibitors
Read More
CSPC Zhongqi Pharmaceutical Technology divulges salts of tyrosine kinase inhibitors
Read More
Medshine Discovery identifies new CSF-1R inhibitors
Read More
New P2X3 antagonists presented by National Institute of Pharmaceutical R&D
Read More
Shanghai Visonpharma synthesizes new TLR7 agonists
Read More
Ono establishes collaborations to discover small molecules targeting GPCRs in metabolic disease
Read More
TAK-676 shows antitumor efficacy as monotherapy or in combination
Read More
MJFF grant supports Neuropore's development of TLR2 antagonist for Parkinson's disease
Read More
AUR-103 in combination with azacytidine and bortezomib for myeloma and leukemia treatment
Read More
Discovery of novel BACE1 inhibitor with optimal balance of potency and drug-like properties
Read More
Testing viruses, vaccines, to increase solid tumor CAR T persistence
Read More
Sionna closes series B financing to support development of CFTR modulators
Read More
Antengene presents anti-CLDN18.2 ATG-022 for the treatment of gastric cancer
Read More
